The Synergism Between Atrial Fibrillation and Heart Failure

Journal of Cardiac Failure

Volumn 14, Issue 4, 2008, Pages 320-326

  Byrne, Melissa ^a   Kaye, David M ^a   Power, John ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

neurohormones; Ovine model

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; NEUROHORMONE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVERSION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY SINUS; DEFIBRILLATION; EXERCISE TEST; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HORMONAL REGULATION; MITRAL VALVE REGURGITATION; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BLOOD PRESSURE; COMORBIDITY; DISEASE PROGRESSION; ELECTRIC COUNTERSHOCK; ENDOTHELIN-1; HEART FAILURE; HEART RATE; MODELS, ANIMAL; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; RISK FACTORS; SHEEP; TIME FACTORS;

EID: 43049159218     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.12.005     Document Type: Article

References (41)

1. Cleland J.G., Chattopadhyay S., Khand A., Houghton T., and Kaye G.C. Prevalence and incidence of arrhythmias and sudden death in heart failure. Heart Fail Rev 7 (2002) 229-242
2. Middlekauff H.R., Stevenson W.G., and Stevenson L.W. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84 (1991) 40-48
3. Carson P.E., Johnson G.R., Dunkman W.B., Fletcher R.D., Farrell L., and Cohn J.N. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 87 (1993) VI102-VI110
4. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325 (1991) 293-302
5. Pozzoli M., Cioffi G., Traversi E., Pinna G.D., Cobelli F., and Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32 (1998) 197-204
6. Parkash R., Maisel W.H., Toca F.M., and Stevenson W.G. Atrial fibrillation in heart failure: high mortality risk even if ventricular function is preserved. Am Heart J 150 (2005) 701-706
7. Byrne M.J., Raman J.S., Alferness C.A., Esler M.D., Kaye D.M., and Power J.M. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Card Fail 8 (2002) 108-115
8. Medvedev O.S., Esler M.D., Angus J.A., Cox H.S., and Eisenhofer G. Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 341 (1990) 192-199
9. Pemberton C.J., Yandle T.G., Charles C.J., Rademaker M.T., Aitken G.D., and Espiner E.A. Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms. J Endocrinol 155 (1997) 541-550
10. Byrne MJ K.D., Mathis M., Reuter D.G., Alferness C.A., and Power J.M. Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy. Circulation 110 (2004) 3088-3092
11. Kaye DM B.M., Alferness C., and Power J. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation 108 (2003) 1795-1797
12. Li D., Fareh S., Leung T.K., and Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100 (1999) 87-95
13. Li D., Melnyk P., Feng J., Wang Z., Petrecca K., Shrier A., and Nattel S. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 101 (2000) 2631-2638
14. Van den Berg M.P., Tuinenburg A.E., Crijns H.J., Van Gelder I.C., Gosselink A.T., and Lie K.I. Heart failure and atrial fibrillation: current concepts and controversies. Heart 77 (1997) 309-313
15. Clark D.M., Plumb V.J., Epstein A.E., and Kay G.N. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 30 (1997) 1039-1045
16. Crijns H.J., Van den Berg M.P., Van Gelder I.C., and Van Veldhuisen D.J. Management of atrial fibrillation in the setting of heart failure. Eur Heart J 18 Suppl C (1997) C45-C49
17. Jais P., Peng J.T., Shah D.C., Garrigue S., Hocini M., Yamane T., et al. Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. J Cardiovasc Electrophysiol 11 (2000) 623-625
18. Lau C.P., Leung W.H., Wong C.K., and Cheng C.H. Haemodynamics of induced atrial fibrillation: a comparative assessment with sinus rhythm, atrial and ventricular pacing. Eur Heart J 11 (1990) 219-224
19. Alboni P., Scarfo S., Fuca G., Paparella N., and Yannacopulu P. Hemodynamics of idiopathic paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 18 (1995) 980-985
20. Rundqvist B., Elam M., Bergmann-Sverrisdottir Y., Eisenhofer G., and Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95 (1997) 169-175
21. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 (1984) 819-823
22. Kaye D.M., Lefkovits J., Jennings G.L., Bergin P., Broughton A., and Esler M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26 (1995) 1257-1263
23. Jayachandran J.V., Sih H.J., Winkle W., Zipes D.P., Hutchins G.D., and Olgin J.E. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation 101 (2000) 1185-1191
24. Friedman H.S., Rodney E., Sinha B., Sharafkhaneh A., Wattanasuwan N., Win M., et al. Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect. J Investig Med 47 (1999) 293-303
25. Wasmund S.L., Li J.M., Page R.L., Joglar J.A., Kowal R.C., Smith M.L., et al. Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects. Circulation 107 (2003) 2011-2015
26. Ogawa Y., Nakao K., Mukoyama M., Hosoda K., Shirakami G., Arai H., et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 69 (1991) 491-500
27. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Mabuchi N., Hayashi M., et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 20 (1999) 1799-1807
28. Ohta Y., Shimada T., Yoshitomi H., Inoue S., Murakami Y., Shimizu H., et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 17 (2001) 415-420
29. Inoue S., Murakami Y., Sano K., Katoh H., and Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 6 (2000) 92-96
30. Jourdain P., Bellorini M., Funck F., Fulla Y., Guillard N., Loiret J., et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail 4 (2002) 263-267
31. Rossi A., Enriquez-Sarano M., Burnett Jr. J.C., Lerman A., Abel M.D., and Seward J.B. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 35 (2000) 1256-1262
32. Horie H., Tsutamoto T., Minai K., Hayashi M., Kito O., and Kinoshita M. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn Circ J 64 (2000) 965-970
33. Mabuchi N., Tsutamoto T., Maeda K., and Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 64 (2000) 765-771
34. Doyama K., Fukumoto M., Takemura G., Tanaka M., Oda T., Hasegawa K., et al. Expression and distribution of brain natriuretic peptide in human right atria. J Am Coll Cardiol 32 (1998) 1832-1838
35. Margulies K.B., Hildebrand Jr. F.L., Lerman A., Perrella M.A., and Burnett Jr. J.C. Increased endothelin in experimental heart failure. Circulation 82 (1990) 2226-2230
36. McMurray J.J., Ray S.G., Abdullah I., Dargie H.J., and Morton J.J. Plasma endothelin in chronic heart failure. Circulation 85 (1992) 1374-1379
37. Love M.P., and McMurray J.J. Endothelin in congestive heart failure. Basic Res Cardiol 91 (1996) 21-29
38. Tuinenburg A.E., Van Veldhuisen D.J., Boomsma F., Van Den Berg M.P., De Kam P.J., and Crijns H.J. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 81 (1998) 1207-1210
39. Brundel B.J., Van Gelder I.C., Tuinenburg A.E., Wietses M., Van Veldhuisen D.J., Van Gilst W.H., et al. Endothelin system in human persistent and paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 12 (2001) 737-742
40. Verheule S., Wilson E., Everett T.T., Shanbhag S., Golden C., and Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 107 (2003) 2615-2622
41. Junker A., Thayssen P., Nielsen B., and Andersen P.E. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology 83 (1993) 14-20